VI Selnet Consortium Meeting (only for Selnet members)

VI SELNET – CONSORTIUM MEETING (Virtual)
(Thursday 2 September 2021) 15:00- 18:15 CET
Sarcoma European Latin-american NETwork
Horizon 2020 Call: H2020-SC1-BHC-2018-2020

Connection from 14:50 CET:
https://us02web.zoom.us/j/88614208477?pwd=aGc1V0FvOUVOZk1FRWdJNlRQOUVTZz09
15:00 – 15:20 CET

INTRODUCTION AND OVERVIEW OF SELNET HIGHLIGHTS (Javier Martin, Nadia Hindi & Alessia Fiorillo – FIIS-FJD)
15:20 – 17:40 Current Status of WPs
15:20- 15:30 WP 2: Definition of reference centers and pathologist Network (Prof Paolo Casali & Paolo dei Tos- INT)
15:30 – 15:40 WP 3: Analysis of healthcare barriers (Dr Dorian García Ortega & Dra Haydee Caro- INCAN)
15:40 – 15:50 WP 5: Continuing medical education (Claudia Valverde-GEIS)
15:50 – 16:10 OBSERVATIONAL AND TRANSLATIONAL PROJECT: WP 6: Multidisciplinary review of clinical cases (Nadia Hindi-FJD) & WP 7: Clinical management quality study (Patricio Ledesma-GEIS) & WP 8: Translational research program (David Moura-FJD): Overview of translational projects: AS/DSRCT/EMC/SFT (CLB, ACC, INT, FJD)
16:10 – 16:20 WP 9: Dissemination and exploitation of results (Matias Chacón-IAF)

16:20 – 16:30 Virtual Coffee Break

16:30 – 16:50 WP 4: Clinical practice guidelines (Julien Bollard & J-Y Blay-CLB)
Plan for adoption SELNET guidelines in LATAM
16:50 – 17:10 Clinical Trial/ study proposals within SELNET (Javier Martín & Nadia Hindi – FJD)
17:10- 17:20 WP 1: Ethics requirements & WP 10: AMENDEMENT
Project Management (Cristina Roldán- FIIS-FJD) & COORDINATION TEAM
17:20-18:15 PENDING CRITICAL ISSUES:
– Should we readdress SELNET objectives for the remaining months?
– How can we improve the number of register cases and the number of cases for MDT discussion?
– SELNET strategy for sarcoma care organization/accreditation in LATAM
– National sarcoma networks/cooperative groups
– SELNET Sustainability
DISCUSSION (ALL)